Biotech VC's
What are some biotech focused vc's that invest in first in class early stage oncology assets and not some risk averse medtech bshit?
Trending Content - Venture Capital Forum
| +6 | New Growth Equity Firms | 3 | 2w |
| +3 | NEA Fellowship 2027 | 0 | 2w |
| +3 | .nnmsk | 1 | 1w |
| +1 | Investment Committee Process Thwarts Creative Thinking | 3 | 11h |
Career Resources
Based on the most helpful WSO content, some top-tier early-stage biotech venture capital firms that are known for leading Series A deals and might be interested in first-in-class early stage oncology assets include:
These firms are akin to the MBB (McKinsey, Bain, BCG) or bulge bracket banks of the biotech VC world, often leading the pack in terms of investment in innovative and groundbreaking biotech startups. They are known for their deep scientific expertise and may be more inclined to invest in cutting-edge oncology research rather than more conservative medtech ventures.
Sources: Healthcare / Biotech Venture Capital?, Biotech finance: from IB to VC / HF to funded startup, Guide To Evaluate a Biotech Company, Guide To Evaluate a Biotech Company
In the US or in Europe?
London
Nextech Invest
Northpond Ventures
5AM Ventures
Ascension Ventures
Yosemite
Dolor id ipsam blanditiis minima. Vel quas earum sed consequuntur qui modi. Totam tempora dolorem omnis. Officiis corrupti voluptatibus voluptas ipsam dolores a. Tenetur laborum alias sed totam fuga numquam tempora aut. Error voluptate nam qui sapiente eligendi sapiente reprehenderit. Repellat minima dolor asperiores amet maiores.
Qui pariatur sunt nostrum omnis debitis et. Fugiat ex aperiam dignissimos similique aut sed. Velit ut quo dolor in facere odit quasi. Voluptatibus ad ducimus porro veritatis sunt ut ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...